Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Total Non-Current Liabilities (2018 - 2026)

10x Genomics' Total Non-Current Liabilities history spans 8 years, with the latest figure at $238.6 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 17.25% to $238.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $238.6 million, a 17.25% increase, with the full-year FY2025 number at $238.6 million, up 17.25% from a year prior.
  • Total Non-Current Liabilities hit $238.6 million in Q4 2025 for 10x Genomics, up from $235.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for TXG hit a ceiling of $238.6 million in Q4 2025 and a floor of $181.9 million in Q3 2021.
  • Historically, Total Non-Current Liabilities has averaged $203.5 million across 5 years, with a median of $200.8 million in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 14.75% in 2021 and later increased 18.01% in 2022.
  • Tracing TXG's Total Non-Current Liabilities over 5 years: stood at $193.0 million in 2021, then rose by 14.11% to $220.3 million in 2022, then dropped by 0.2% to $219.8 million in 2023, then dropped by 7.44% to $203.5 million in 2024, then rose by 17.25% to $238.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for TXG at $238.6 million in Q4 2025, $235.8 million in Q3 2025, and $200.6 million in Q2 2025.